Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2004AIDS

Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir

View Full Paper
Ask AI
Bookmark
Share

Authors

AMAllison MartinImperial College LondonDSDon SmithUNSW SydneyACAndrew CarrSt Vincent's Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Martin et al. (2004) studied this question.

synapsesocial.com/papers/6a6f5853b5c1fe5ca9df9815https://doi.org/10.1097/00002030-200404300-00011
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis1994 · 343 citations
  2. 2Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection2000 · 521 citations
  3. 3Lipodystrophy, Metabolic Disorders, and Human Immunodeficiency Virus Infection: Aquitaine Cohort, France, 19992000 · 175 citations
  4. 4HIV lipodystrophy: prevalence, severity and correlates of risk in Australia2003 · 217 citations
  5. 5Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy2001 · 233 citations